A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, and Active-Referenced Study Evaluating the Efficacy and Safety of Three Fixed Dose Regimens of Lu AA34893 in the Treatment of Major Depressive Disorder.

Trial Profile

A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, and Active-Referenced Study Evaluating the Efficacy and Safety of Three Fixed Dose Regimens of Lu AA34893 in the Treatment of Major Depressive Disorder.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 22 Dec 2012

At a glance

  • Drugs LU AA34893 (Primary) ; Venlafaxine (Primary)
  • Indications Major depressive disorder
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 19 May 2012 Company (Pfizer) added to he associations filed as reported by European Clinical Trials Database record.
    • 28 Apr 2012 Additional trial location added as reported by European Clinical Trials Database.
    • 12 Apr 2012 Additional trial locations added as reported by European Clinical Trials Database.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top